Akiyuki Wakita

Associate professor / Lecturer

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Akiyuki Wakita is an Associate Professor at Akita University Hospital in Japan. His research areas include thoracic esophageal cancer treatment, focusing on neoadjuvant chemoradiotherapy and the impact of genetic polymorphisms on treatment outcomes. Recent publications highlight his work on assessing lymph node metastasis risks and analyzing the effects of surgical interventions in elderly patients. He is dedicated to improving patient prognosis through innovative research methodologies.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (1)

Keiji Kuba

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Akiyuki Wakita

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Preoperative neoadjuvant chemoradiotherapy provides borderline resectable thoracic esophageal cancer with equivalent treatment results as clinically T3 thoracic esophageal cancer

A Multi-institutional Study to Diagnose the Risk of Lymph Node Metastasis Using a CRP Genetic Polymorphism Test Kit in pT1, cN0 Thoracic Esophageal Squamous Cell Carcinoma

Association between ABCC2 polymorphism and hematological toxicity in patients with esophageal cancer receiving platinum plus 5-fluorouracil therapy

Changes in Serum Trace Element Concentrations before and after Surgery in Resectable Breast Cancer

Does Esophagectomy Provide a Survival Advantage to Patients Aged 80 Years or Older? Analyzing 5066 Patients in the National Database of Hospital-based Cancer Registries in Japan

PET-Uptake Reduction into Lymph Nodes After Neoadjuvant Therapy is Highly Predictive of Prognosis for Patients Who have Thoracic Esophageal Squamous Cell Carcinoma Treated with Chemoradiotherapy Plus Esophagectomy

Peritumoral CD16b positive-neutrophil accumulation strongly correlates with regional lymph node metastasis in thoracic esophageal squamous cell cancer

Approaches to resection of recurrent solitary mediastinal lymph nodes after esophagectomy

Differences in treatment and survival between elderly patients with thoracic esophageal cancer in metropolitan areas and other areas

Effects of SLC31A1 and ATP7B polymorphisms on platinum resistance in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiotherapy

Collaborators (1)

Keiji Kuba

Make your next move.